FDA
-
-
-
-
-
-
-
Microbix Schedules Release of Results for Q4 Fiscal 2025
-
-
-
-
-
-
-
Microbix Addresses Cybersecurity Incident
-
-
-
-
-
-
-
MBX Biosciences begins phase 1 obesity drug trial
-
-
-
-
-
-
-
Microbix Exhibiting & Presenting at ADLM
-
-
-
-
-
-
-
Microbix Reports Results for Q2 Fiscal 2025
-
-
-
-
-
-
-
Microbix Exhibiting at ESCMID Global 2025
-
-
-
-
-
-
-
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

